International Rx-to-OTC Switch Forecasts United States
Published May 2004
View
PDF brochure
The fifth report in Kline’s Rx-to-OTC-switch series
provides forecasts of switch-candidate brands and 14
therapeutic classes in United States from 2004 to 2009.
The study offers realistic, up-to-date forecasts based
on comprehensive primary research with industry executives.
It also provides insights on reimbursement and payers’
perspectives on switches, including direct input from
government health ministries, third-party payers, and
managed care organizations. The study includes a thorough
review of regulatory issues in United States and an
in-depth analysis of the retail environment for Rx-to-OTC
switches. (Y58109)
Australia
• Japan
• New
Zealand • France
• Germany
• Italy
• United
Kingdom • Canada
Contact
|
